Although the in-house cohort study is limited by sample size and the mRNA data are from the TCGA cohort, it remains an exciting observation that low levels of MATR3 notably correlated with shorter survival rates in patients with ccRCC. This evidence concerns the gene MATR3 and nonpapillary renal cell carcinoma.